Our Portfolio 

Our portfolio reflects the scale and diversity of the broader healthcare venture capital market.


For over 13 years, we have created customized solutions for venture funds, corporate venture funds, limited partnership interests, operating companies, and individual shareholders.

Singular Genomics is a biotech company working to accelerate genomics for the advancement of science and medicine.


SomaLogic is a privately owned American protein biomarker discovery and clinical diagnostics company.


Oxford Nanopore Technologies  is developing and selling nanopore sequencing products for the direct, electronic analysis of single molecules.


Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.